title: [Microcalorimetric investigation on the interaction of six alkaloids from rhizoma coptidis].
abstract: How to identify active constituents of traditional Chinese medicines (TCMs) and study their interactions are key problems in the development of TCMs. The inhibitory effect of six alkaloids from Rhizoma Coptidis (RC) on Shigella dysenteriae (S. dysenteria) growth had been investigated by microcalorimetry in this study. Main active constituents of RC were confirmed by comparing their contributions to the bacteriostatic effect, and the interactions among active constituents were further researched. According to the result, in 0.8 mg-mL-1 extract of RC, the contributions of six active alkaloids including berberine, coptisine, epiberberine, palmatine and the combination of jatrorrhizine and columbamine were 52.83%, 36.31%, 2.49%, 4.27% and 3.21%, respectively. Therefore, berberine and coptisine were the main active constituents of RC that inhibited the growth of S. dysenteria. The study of interactions among the six alkaloids indicated that, 1 there were some contstituents antagonizing the inhibitory effect of RC, 2 there was a synergy effect between berberine and coptisine, 3 there were additive effects between other four alkaloids and the main active constituents. These results may provide some useful references for the establishment of the quality standard for RC and the development of multi-component TCMs.
authors.forename: Jun-Xian
authors.initials: JX
authors.lastname: Li
authors.forename: Jia-Yi
authors.initials: JY
authors.lastname: Wang
authors.forename: Le-Le
authors.initials: LL
authors.lastname: Zhang
authors.forename: Dan
authors.initials: D
authors.lastname: Yan
authors.forename: Rui-Lin
authors.initials: RL
authors.lastname: Wang
authors.forename: Bao-Cai
authors.initials: BC
authors.lastname: Li
authors.forename: Xiao-He
authors.initials: XH
authors.lastname: Xiao
mesh_terms: D000470:Alkaloids / Q000032:analysis / Q000494:pharmacology*; D001599:Berberine / Q000031:analogs & derivatives* / Q000032:analysis / Q000494:pharmacology*; D001600:Berberine Alkaloids / Q000032:analysis / Q000494:pharmacology; D039323:Coptis / Q000737:chemistry*; D004347:Drug Interactions; D004357:Drug Synergism; D010946:Plants, Medicinal / Q000737:chemistry; D011786:Quality Control; D027343:Rhizome / Q000737:chemistry; D012762:Shigella dysenteriae / Q000187:drug effects / Q000254:growth & development
chemical_list: D000470:Alkaloids; D001600:Berberine Alkaloids; C055785:jatrorrhizine; C034384:coptisine; D001599:Berberine; C061432:epiberberine; C055786:columbamine; C005413:palmatine